MHC vs. SUN, RUA, DEMG, POLX, BELL, IHC, BSFA, GENF, ROQ, and VAL
Should you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Surgical Innovations Group (SUN), RUA Life Sciences (RUA), Deltex Medical Group (DEMG), Polarean Imaging (POLX), Belluscura (BELL), Inspiration Healthcare Group (IHC), BSF Enterprise (BSFA), Genflow Biosciences (GENF), Roquefort Therapeutics (ROQ), and ValiRx (VAL). These companies are all part of the "medical" sector.
MyHealthChecked (LON:MHC) and Surgical Innovations Group (LON:SUN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, community ranking, earnings, risk, valuation and profitability.
In the previous week, Surgical Innovations Group had 7 more articles in the media than MyHealthChecked. MarketBeat recorded 7 mentions for Surgical Innovations Group and 0 mentions for MyHealthChecked. Surgical Innovations Group's average media sentiment score of 0.22 beat MyHealthChecked's score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the news media.
MyHealthChecked has higher revenue and earnings than Surgical Innovations Group.
MyHealthChecked has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500. Comparatively, Surgical Innovations Group has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500.
3.1% of MyHealthChecked shares are owned by institutional investors. Comparatively, 43.7% of Surgical Innovations Group shares are owned by institutional investors. 38.6% of MyHealthChecked shares are owned by company insiders. Comparatively, 46.2% of Surgical Innovations Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
MyHealthChecked has a net margin of 1.26% compared to Surgical Innovations Group's net margin of -0.83%. MyHealthChecked's return on equity of 2.22% beat Surgical Innovations Group's return on equity.
Surgical Innovations Group received 121 more outperform votes than MyHealthChecked when rated by MarketBeat users.
Summary
MyHealthChecked beats Surgical Innovations Group on 7 of the 12 factors compared between the two stocks.
Get MyHealthChecked News Delivered to You Automatically
Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MyHealthChecked Competitors List
Related Companies and Tools
